⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Sepragen Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Sepragen Corporation
↗Union City, California, USA
Sepragen Corporation is a specialized biotechnology company that develops, manufactures, and distributes advanced separation and purification technologies, primarily focused on radial flow chromatography (RFC). Their products, including Superflo® columns and QuantaSep® systems, are designed to streamline the manufacturing of biopharmaceuticals, vaccines, and diagnostics by enabling faster, more efficient, and cost-effective scale-up from laboratory to production.
Founded in 1985 and headquartered in Union City, California, the company serves a global customer base that includes major pharmaceutical and biotechnology firms. Their technology has been utilized in the production of numerous FDA-approved drugs and biologics, playing a critical role in bioprocessing workflows for recombinant proteins, monoclonal antibodies, and genetic therapy vectors.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:1985
Ownership:private
Status:operating
FUNDING
Investors:Shimadzu Corporation (Strategic Investor)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Equipment Provider)
Modalities:Bioprocessing Equipment, Chromatography
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Shimadzu Corporation (Strategic investment and partnership for bioprocess chromatography), Labindia Instruments (Exclusive distributor in India)
COMPETITION
Position:Niche Player
Competitors:Repligen Corporation, Harvard Bioscience, Regis Technologies
LEADERSHIP
Key Executives:
Vinit Saxena - CEO/President
LINKS
Website:sepragen.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sepragen Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.